Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
2016-2020 | 499 | 38 | 7.6 | 135 | 27.1 | 178 | 35.7 | 112 | 22.4 | 36 | 7.2 |
2015-2019 | 512 | 34 | 6.6 | 158 | 30.9 | 175 | 34.2 | 108 | 21.1 | 37 | 7.2 |
2014-2018 | 492 | 34 | 6.9 | 156 | 31.7 | 160 | 32.5 | 100 | 20.3 | 42 | 8.5 |
2013-2017 | 494 | 32 | 6.5 | 159 | 32.2 | 165 | 33.4 | 97 | 19.6 | 41 | 8.3 |
2012-2016 | 488 | 34 | 7.0 | 154 | 31.6 | 165 | 33.8 | 99 | 20.3 | 36 | 7.4 |
2011-2015 | 471 | 31 | 6.6 | 150 | 31.8 | 174 | 36.9 | 92 | 19.5 | 24 | 5.1 |
2010-2014 | 485 | 31 | 6.4 | 143 | 29.5 | 183 | 37.7 | 105 | 21.6 | 23 | 4.7 |
2009-2013 | 501 | 30 | 6.0 | 154 | 30.7 | 196 | 39.1 | 103 | 20.6 | 18 | 3.6 |
2008-2012 | 523 | 32 | 6.1 | 178 | 34.0 | 194 | 37.1 | 95 | 18.2 | 24 | 4.6 |
2007-2011 | 516 | 21 | 4.1 | 191 | 37.0 | 187 | 36.2 | 93 | 18.0 | 24 | 4.7 |
2006-2010 | 530 | 22 | 4.2 | 195 | 36.8 | 183 | 34.5 | 96 | 18.1 | 34 | 6.4 |
2005-2009 | 524 | 18 | 3.4 | 194 | 37.0 | 184 | 35.1 | 83 | 15.8 | 45 | 8.6 |
2004-2008 | 516 | 18 | 3.5 | 196 | 38.0 | 183 | 35.5 | 77 | 14.9 | 42 | 8.1 |
2003-2007 | 522 | 14 | 2.7 | 184 | 35.2 | 201 | 38.5 | 78 | 14.9 | 45 | 8.6 |
2002-2006 | 542 | 14 | 2.6 | 186 | 34.3 | 221 | 40.8 | 71 | 13.1 | 50 | 9.2 |
2001-2005 | 573 | 12 | 2.1 | 190 | 33.2 | 233 | 40.7 | 76 | 13.3 | 62 | 10.8 |
2000-2004 | 588 | 14 | 2.4 | 200 | 34.0 | 246 | 41.8 | 67 | 11.4 | 61 | 10.4 |
1999-2003 | 592 | 11 | 1.9 | 183 | 30.9 | 260 | 43.9 | 68 | 11.5 | 70 | 11.8 |
1998-2002 | 604 | 15 | 2.5 | 192 | 31.8 | 261 | 43.2 | 66 | 10.9 | 70 | 11.6 |
1997-2001 | 582 | 14 | 2.4 | 175 | 30.1 | 257 | 44.2 | 68 | 11.7 | 68 | 11.7 |
1996-2000 | 572 | 16 | 2.8 | 175 | 30.6 | 245 | 42.8 | 71 | 12.4 | 65 | 11.4 |
1995-1999 | 543 | 17 | 3.1 | 164 | 30.2 | 220 | 40.5 | 77 | 14.2 | 65 | 12.0 |
1994-1998 | 556 | 25 | 4.5 | 173 | 31.1 | 206 | 37.1 | 77 | 13.8 | 75 | 13.5 |
1993-1997 | 521 | 26 | 5.0 | 158 | 30.3 | 181 | 34.7 | 82 | 15.7 | 74 | 14.2 |
1992-1996 | 523 | 26 | 5.0 | 159 | 30.4 | 177 | 33.8 | 74 | 14.1 | 87 | 16.6 |
1991-1995 | 558 | 28 | 5.0 | 162 | 29.0 | 197 | 35.3 | 77 | 13.8 | 94 | 16.8 |
1990-1994 | 555 | 27 | 4.9 | 150 | 27.0 | 209 | 37.7 | 72 | 13.0 | 97 | 17.5 |
1989-1993 | 528 | 20 | 3.8 | 144 | 27.3 | 198 | 37.5 | 68 | 12.9 | 98 | 18.6 |
1988-1992 | 542 | 17 | 3.1 | 148 | 27.3 | 197 | 36.3 | 68 | 12.5 | 112 | 20.7 |
1987-1991 | 541 | 19 | 3.5 | 154 | 28.5 | 189 | 34.9 | 67 | 12.4 | 112 | 20.7 |
1986-1990 | 494 | 15 | 3.0 | 149 | 30.2 | 169 | 34.2 | 59 | 11.9 | 102 | 20.6 |
1985-1989 | 513 | 16 | 3.1 | 163 | 31.8 | 155 | 30.2 | 72 | 14.0 | 107 | 20.9 |
Notes: |
---|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
Last Updated : April 13, 2023 |